{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:39:53Z","timestamp":1707525593022},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"DOI":"10.7759\/cureus.51493","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T07:03:22Z","timestamp":1704179002000},"source":"Crossref","is-referenced-by-count":0,"title":["Descriptive Analysis of Pre-existing Data on Eosinophilic Esophagitis and Associated Morbidities in Cleveland Clinic Abu Dhabi, United Arab Emirates"],"prefix":"10.7759","author":[{"given":"Mohamad","family":"Abuzakouk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahir","family":"Chouikrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.003","article-title":"Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients","volume":"6","author":"Straumann A","year":"2008","unstructured":"Straumann A, Bussmann C, Zuber M, Vannini S, Simon HU, Schoepfer A. Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol. 2008, 6:598-600. 10.1016\/j.cgh.2008.02.003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2013.10.027","article-title":"A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease","volume":"79","author":"Dellon ES","year":"2014","unstructured":"Dellon ES, Kim HP, Sperry SL, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc. 2014, 79:577-85.e4. 10.1016\/j.gie.2013.10.027","journal-title":"Gastrointest Endosc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano I","year":"2013","unstructured":"Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013, 62:489-95. 10.1136\/gutjnl-2011-301817","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2050640616689525","article-title":"Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults","volume":"5","author":"Lucendo AJ","year":"2017","unstructured":"Lucendo AJ, Molina-Infante J, Arias \u00c1, et al.. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017, 5:335-58. 10.1177\/2050640616689525","journal-title":"United European Gastroenterol J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.06.065","article-title":"Pathophysiology of eosinophilic esophagitis","volume":"154","author":"O'Shea KM","year":"2018","unstructured":"O'Shea KM, Aceves SS, Dellon ES, Gupta SK, Spergel JM, Furuta GT, Rothenberg ME. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018, 154:333-45. 10.1053\/j.gastro.2017.06.065","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.119917","article-title":"Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response","volume":"108","author":"Straumann A","year":"2001","unstructured":"Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001, 108:954-61. 10.1067\/mai.2001.119917","journal-title":"J Allergy Clin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.07.055","article-title":"Advances in clinical management of eosinophilic esophagitis","volume":"147","author":"Dellon ES","year":"2014","unstructured":"Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014, 147:1238-54. 10.1053\/j.gastro.2014.07.055","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the agree conference","volume":"155","author":"Dellon ES","year":"2018","unstructured":"Dellon ES, Liacouras CA, Molina-Infante J, et al.. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the agree conference. Gastroenterology. 2018, 155:1022-1033.e10. 10.1053\/j.gastro.2018.07.009","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.47","article-title":"Esophageal eosinophilia is increased in rural areas with low population density: results from a national pathology database","volume":"109","author":"Jensen ET","year":"2014","unstructured":"Jensen ET, Hoffman K, Shaheen NJ, Genta RM, Dellon ES. Esophageal eosinophilia is increased in rural areas with low population density: results from a national pathology database. Am J Gastroenterol. 2014, 109:668-75. 10.1038\/ajg.2014.47","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e318290d15a","article-title":"Early life exposures as risk factors for pediatric eosinophilic esophagitis","volume":"57","author":"Jensen ET","year":"2013","unstructured":"Jensen ET, Kappelman MD, Kim HP, Ringel-Kulka T, Dellon ES. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013, 57:67-71. 10.1097\/MPG.0b013e318290d15a","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.016","article-title":"Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups","volume":"134","author":"Kapel RC","year":"2008","unstructured":"Kapel RC, Miller JK, Torres C, Aksoy S, Lash R, Katzka DA. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology. 2008, 134:1316-21. 10.1053\/j.gastro.2008.02.016","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.07.027","article-title":"Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy","volume":"128","author":"van Nimwegen FA","year":"2011","unstructured":"van Nimwegen FA, Penders J, Stobberingh EE, et al.. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol. 2011, 128:948-55.e1-3. 10.1016\/j.jaci.2011.07.027","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.09.008","article-title":"Prevalence of eosinophilic esophagitis in the United States","volume":"12","author":"Dellon ES","year":"2014","unstructured":"Dellon ES, Jensen ET, Martin CF, Shaheen NJ, Kappelman MD. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol. 2014, 12:589-96.e1. 10.1016\/j.cgh.2013.09.008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1502863","article-title":"Eosinophilic esophagitis","volume":"373","author":"Furuta GT","year":"2015","unstructured":"Furuta GT, Katzka DA. Eosinophilic esophagitis. N Engl J Med. 2015, 373:1640-8. 10.1056\/NEJMra1502863","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-011-1540-4","article-title":"Omalizumab in the treatment of eosinophilic esophagitis and food allergy","volume":"170","author":"Rocha R","year":"2011","unstructured":"Rocha R, Vitor AB, Trindade E, Lima R, Tavares M, Lopes J, Dias JA. Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr. 2011, 170:1471-4. 10.1007\/s00431-011-1540-4","journal-title":"Eur J Pediatr"},{"key":"ref16","article-title":"[Inflammatory cytokines (IL-4, IL-5 and IL-13)]","volume":"59","author":"Maeda S","year":"2001","unstructured":"Maeda S, Yanagihara Y. [Inflammatory cytokines (IL-4, IL-5 and IL-13)]. Nihon Rinsho. 2001, 59:1894-9.","journal-title":"Nihon Rinsho"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4482","article-title":"Eosinophilic esophagitis: update on management and controversies","volume":"359","author":"Chen JW","year":"2017","unstructured":"Chen JW, Kao JY. Eosinophilic esophagitis: update on management and controversies. BMJ. 2017, 359:j4482. 10.1136\/bmj.j4482","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-018-1498-3","article-title":"Epithelial-stromal crosstalk and fibrosis in eosinophilic esophagitis","volume":"54","author":"Muir AB","year":"2019","unstructured":"Muir AB, Wang JX, Nakagawa H. Epithelial-stromal crosstalk and fibrosis in eosinophilic esophagitis. J Gastroenterol. 2019, 54:10-8. 10.1007\/s00535-018-1498-3","journal-title":"J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.09.013","article-title":"Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland","volume":"128","author":"Hruz P","year":"2011","unstructured":"Hruz P, Straumann A, Bussmann C, et al.. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol. 2011, 128:1349-50.e5. 10.1016\/j.jaci.2011.09.013","journal-title":"J Allergy Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12746","article-title":"Clinical features of eosinophilic esophagitis: differences between Asian and Western populations","volume":"30 Suppl 1","author":"Ishimura N","year":"2015","unstructured":"Ishimura N, Shimura S, Jiao D, et al.. Clinical features of eosinophilic esophagitis: differences between Asian and Western populations. J Gastroenterol Hepatol. 2015, 30 Suppl 1:71-7. 10.1111\/jgh.12746","journal-title":"J Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/526037","article-title":"Eosinophilic esophagitis in a developing country: is it different from developed countries?","volume":"2013","author":"Al-Hussaini A","year":"2013","unstructured":"Al-Hussaini A, Semaan T, El Hag I. Eosinophilic esophagitis in a developing country: is it different from developed countries?. Gastroenterol Res Pract. 2013, 2013:526037. 10.1155\/2013\/526037","journal-title":"Gastroenterol Res Pract"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.77242","article-title":"Eosinophilic esophagitis in Saudi children: symptoms, histology and endoscopy results","volume":"17","author":"Hasosah MY","year":"2011","unstructured":"Hasosah MY, Sukkar GA, Alsahafi AF, Thabit AO, Fakeeh ME, Al-Zahrani DM, Satti MB. Eosinophilic esophagitis in Saudi children: symptoms, histology and endoscopy results. Saudi J Gastroenterol. 2011, 17:119-23. 10.4103\/1319-3767.77242","journal-title":"Saudi J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/328253","article-title":"Eosinophilic esophagitis in children from Western saudi arabia: relative frequency, clinical, pathological, endoscopic, and immunological study","volume":"2012","author":"Saadah OI","year":"2012","unstructured":"Saadah OI, Aburiziza AJ, Abu Shakra RI. Eosinophilic esophagitis in children from Western saudi arabia: relative frequency, clinical, pathological, endoscopic, and immunological study. Gastroenterol Res Pract. 2012, 2012:328253. 10.1155\/2012\/328253","journal-title":"Gastroenterol Res Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2021.109975","article-title":"Clinico-pathological characteristics of eosinophilic esophagitis in Jordanian children","volume":"17","author":"Altamimi E","year":"2022","unstructured":"Altamimi E, Ahmad B, Abu-Aqoulah A, Rawabdeh N. Clinico-pathological characteristics of eosinophilic esophagitis in Jordanian children. Prz Gastroenterol. 2022, 17:207-12. 10.5114\/pg.2021.109975","journal-title":"Prz Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2012.01395.x","article-title":"Frequency of eosinophilic esophagitis in patients with esophageal symptoms: a single-center Turkish experience","volume":"26","author":"Altun R","year":"2013","unstructured":"Altun R, Akbas E, Y\u0131ld\u0131r\u0131m AE, \u00d6cal S, Korkmaz M, Selcuk H. Frequency of eosinophilic esophagitis in patients with esophageal symptoms: a single-center Turkish experience. Dis Esophagus. 2013, 26:776-81. 10.1111\/j.1442-2050.2012.01395.x","journal-title":"Dis Esophagus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2018.071","article-title":"Changing concept of the prevalence of eosinophilic esophagitis: visible and hidden patients","volume":"51","author":"Lee H","year":"2018","unstructured":"Lee H. Changing concept of the prevalence of eosinophilic esophagitis: visible and hidden patients. Clin Endosc. 2018, 51:307-9. 10.5946\/ce.2018.071","journal-title":"Clin Endosc"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-021-00809-2","article-title":"Eosinophilic gastritis\/gastroenteritis","volume":"23","author":"Chen PH","year":"2021","unstructured":"Chen PH, Anderson L, Zhang K, Weiss GA. Eosinophilic gastritis\/gastroenteritis. Curr Gastroenterol Rep. 2021, 23:13. 10.1007\/s11894-021-00809-2","journal-title":"Curr Gastroenterol Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.01.060","article-title":"Epidemiology of nonesophageal eosinophilic gastrointestinal diseases in symptomatic patients: a systematic review and meta-analysis","volume":"8","author":"Licari A","year":"2020","unstructured":"Licari A, Votto M, Scudeller L, De Silvestri A, Rebuffi C, Cianferoni A, Marseglia GL. Epidemiology of nonesophageal eosinophilic gastrointestinal diseases in symptomatic patients: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2020, 8:1994-2003.e2. 10.1016\/j.jaip.2020.01.060","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.05.050","article-title":"Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017","volume":"15","author":"Mansoor E","year":"2017","unstructured":"Mansoor E, Saleh MA, Cooper GS. Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017. Clin Gastroenterol Hepatol. 2017, 15:1733-41. 10.1016\/j.cgh.2017.05.050","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.011","article-title":"Innate lymphoid cells in allergic and nonallergic inflammation","volume":"138","author":"Morita H","year":"2016","unstructured":"Morita H, Moro K, Koyasu S. Innate lymphoid cells in allergic and nonallergic inflammation. J Allergy Clin Immunol. 2016, 138:1253-64. 10.1016\/j.jaci.2016.09.011","journal-title":"J Allergy Clin Immunol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.05.048","article-title":"Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis","volume":"136","author":"Doherty TA","year":"2015","unstructured":"Doherty TA, Baum R, Newbury RO, et al.. Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis. J Allergy Clin Immunol. 2015, 136:792-4.e3. 10.1016\/j.jaci.2015.05.048","journal-title":"J Allergy Clin Immunol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2015.09.016","article-title":"Type 2 innate lymphoid cells: a novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma","volume":"109","author":"Liu T","year":"2015","unstructured":"Liu T, Wu J, Zhao J, et al.. Type 2 innate lymphoid cells: a novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma. Respir Med. 2015, 109:1391-6. 10.1016\/j.rmed.2015.09.016","journal-title":"Respir Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000865","article-title":"Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: estimates from a national administrative database","volume":"62","author":"Jensen ET","year":"2016","unstructured":"Jensen ET, Martin CF, Kappelman MD, Dellon ES. Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: estimates from a national administrative database. J Pediatr Gastroenterol Nutr. 2016, 62:36-42. 10.1097\/MPG.0000000000000865","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref34","unstructured":"U.S. Food and Drug Administration. FDA approves first treatment for eosinophilic esophagitis, a chronic immune disorder. (2022). Accessed: May 20, 2022: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-eosinophilic-esophagitis-chronic-imm...."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2014.02.002","article-title":"Epidemiology of eosinophilic esophagitis","volume":"43","author":"Dellon ES","year":"2014","unstructured":"Dellon ES. Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am. 2014, 43:201-18. 10.1016\/j.gtc.2014.02.002","journal-title":"Gastroenterol Clin North Am"},{"key":"ref36","article-title":"World Population Prospects 2022: Summary of Results","author":"United Nations","year":"2022","unstructured":"United Nations. World Population Prospects 2022: Summary of Results.  United Nations, New York, NY; 2022."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-015-0558-5","article-title":"Eosinophilic esophagitis and gastroenteritis","volume":"15","author":"Cianferoni A","year":"2015","unstructured":"Cianferoni A, Spergel JM. Eosinophilic esophagitis and gastroenteritis. Curr Allergy Asthma Rep. 2015, 15:58. 10.1007\/s11882-015-0558-5","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.03.025","article-title":"A clinical severity index for eosinophilic esophagitis: development, consensus, and future directions","volume":"163","author":"Dellon ES","year":"2022","unstructured":"Dellon ES, Khoury P, Muir AB, et al.. A clinical severity index for eosinophilic esophagitis: development, consensus, and future directions. Gastroenterology. 2022, 163:59-76. 10.1053\/j.gastro.2022.03.025","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13279","article-title":"Multidisciplinary approach to the management of adult eosinophilic oesophagitis in the United Kingdom","volume":"48","author":"Hunter H","year":"2018","unstructured":"Hunter H, Pupinyte K, Wong T, et al.. Multidisciplinary approach to the management of adult eosinophilic oesophagitis in the United Kingdom. Clin Exp Allergy. 2018, 48:1752-6. 10.1111\/cea.13279","journal-title":"Clin Exp Allergy"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02110-8","article-title":"Improving care in eosinophil-associated diseases: a charter","volume":"39","author":"Jackson DJ","year":"2022","unstructured":"Jackson DJ, Akuthota P, Andradas R, et al.. Improving care in eosinophil-associated diseases: a charter. Adv Ther. 2022, 39:2323-41. 10.1007\/s12325-022-02110-8","journal-title":"Adv Ther"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2022.43.210102","article-title":"Outcomes of eosinophilic esophagitis in patients managed in a multidisciplinary clinic","volume":"43","author":"McMurray JC","year":"2022","unstructured":"McMurray JC, Clair BS, Spriet SW, Min SB, Brooks DI, Mikita CP. Outcomes of eosinophilic esophagitis in patients managed in a multidisciplinary clinic. Allergy Asthma Proc. 2022, 43:78-84. 10.2500\/aap.2022.43.210102","journal-title":"Allergy Asthma Proc"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.5009\/gnl17056","article-title":"A prospective study on the prevalence, extent of disease and outcome of eosinophilic gastroenteritis in patients presenting with lower abdominal symptoms","volume":"12","author":"Hui CK","year":"2018","unstructured":"Hui CK, Hui NK. A prospective study on the prevalence, extent of disease and outcome of eosinophilic gastroenteritis in patients presenting with lower abdominal symptoms. Gut Liver. 2018, 12:288-96. 10.5009\/gnl17056","journal-title":"Gut Liver"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1705784","article-title":"Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies","volume":"16","author":"Lucendo AJ","year":"2020","unstructured":"Lucendo AJ. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies. Expert Rev Clin Immunol. 2020, 16:63-77. 10.1080\/1744666X.2019.1705784","journal-title":"Expert Rev Clin Immunol"},{"key":"ref44","article-title":"Eosinophilic gastroenteritis: clinical profiles and treatment outcomes, a retrospective study of 18 adult patients in a Singapore Tertiary Hospital","volume":"70","author":"Wong GW","year":"2015","unstructured":"Wong GW, Lim KH, Wan WK, Low SC, Kong SC. Eosinophilic gastroenteritis: clinical profiles and treatment outcomes, a retrospective study of 18 adult patients in a Singapore Tertiary Hospital. Med J Malaysia. 2015, 70:232-7.","journal-title":"Med J Malaysia"},{"key":"ref45","article-title":"Update on emerging pharmacologic therapies for patients with eosinophilic esophagitis","volume":"18","author":"Syverson EP","year":"2022","unstructured":"Syverson EP, Hait E. Update on emerging pharmacologic therapies for patients with eosinophilic esophagitis. Gastroenterol Hepatol (N Y). 2022, 18:207-12.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001949","article-title":"Long-term outcomes of the six-food elimination diet and food reintroduction in a large cohort of adults with eosinophilic esophagitis","volume":"117","author":"Zalewski A","year":"2022","unstructured":"Zalewski A, Doerfler B, Krause A, Hirano I, Gonsalves N. Long-term outcomes of the six-food elimination diet and food reintroduction in a large cohort of adults with eosinophilic esophagitis. Am J Gastroenterol. 2022, 117:1963-70. 10.14309\/ajg.0000000000001949","journal-title":"Am J Gastroenterol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.12.034","article-title":"Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis","volume":"12","author":"Wolf WA","year":"2014","unstructured":"Wolf WA, Jerath MR, Sperry SL, Shaheen NJ, Dellon ES. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014, 12:1272-9. 10.1016\/j.cgh.2013.12.034","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8660-1","article-title":"Dietary therapy for eosinophilic esophagitis: elimination and reintroduction","volume":"55","author":"Kliewer KL","year":"2018","unstructured":"Kliewer KL, Cassin AM, Venter C. Dietary therapy for eosinophilic esophagitis: elimination and reintroduction. Clin Rev Allergy Immunol. 2018, 55:70-87. 10.1007\/s12016-017-8660-1","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i28.9549","article-title":"Esophageal dilations in eosinophilic esophagitis: a single center experience","volume":"20","author":"Ukleja A","year":"2014","unstructured":"Ukleja A, Shiroky J, Agarwal A, Allende D. Esophageal dilations in eosinophilic esophagitis: a single center experience. World J Gastroenterol. 2014, 20:9549-55. 10.3748\/wjg.v20.i28.9549","journal-title":"World J Gastroenterol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.433","article-title":"Eosinophilic esophagitis dilation in the community-try it-you will like it-but start low and go slow","volume":"111","author":"Richter JE","year":"2016","unstructured":"Richter JE. Eosinophilic esophagitis dilation in the community-try it-you will like it-but start low and go slow. Am J Gastroenterol. 2016, 111:214-6. 10.1038\/ajg.2015.433","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/207186-descriptive-analysis-of-pre-existing-data-on-eosinophilic-esophagitis-and-associated-morbidities-in-cleveland-clinic-abu-dhabi-united-arab-emirates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:26Z","timestamp":1707509546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/207186-descriptive-analysis-of-pre-existing-data-on-eosinophilic-esophagitis-and-associated-morbidities-in-cleveland-clinic-abu-dhabi-united-arab-emirates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.51493","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}